MedPath

Phase II study of endobronchial ultrasound (EBUS)-guided transbronchial biopsy using thin bronchoscope (XBF-3B260Y1) with miniature probe (XUM-S20-17R) for diagnosis of peripheral pulmonary lesions

Phase 2
Conditions
Benign or malignant pulmonary lesions
Registration Number
JPRN-UMIN000000509
Lead Sponsor
agoya Medical Center
Brief Summary

A total of 86 patients with suspected peripheral lesions were included in this prospective study. Twelve patients with endobronchial lesions within the segmental bronchi and 3 patients who did not return to follow-up were excluded from this analysis. Thus, a total of 71 patients with peripheral pulmonary lesions (mean size, 31.2 +- 12.7 mm) were included in the final analysis. The mean bronchus level reached with the thin bronchoscope was 4.6 generations. Diagnostic histologic specimens were obtained in 49 of 71 patients (69%: 80% for malignant lesions and 52% for benign lesions). There were no significant complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

1. Serious concomitant medical illness 2. Obvious central pulmonary lesion 3. Diffuse pulmonary lesions 4. Re-examination due to prior failure in this trial 5. Obvious bleeding tendency 6. Pregnancy 7. Other clinical difficulties in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic yield
Secondary Outcome Measures
NameTimeMethod
1. Frequency of adverse effects 2. Level of bronchus reached 3. Visibility on EBUS 4. Direct visibility of lesions with bronchoscope 5. Optimal number of biopsies
© Copyright 2025. All Rights Reserved by MedPath